- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
450
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
450 companies
Jerusalem Pharmaceuticals
Market Cap: US$67.5m
Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
JPH
US$3.75
7D
0.5%
1Y
-1.3%
Diaceutics
Market Cap: UK£106.5m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.26
7D
-7.4%
1Y
24.1%
Assertio Holdings
Market Cap: US$69.0m
A commercial pharmaceutical company, provides various products to patients in the United States.
ASRT
US$0.72
7D
-5.2%
1Y
-30.5%
Unicycive Therapeutics
Market Cap: US$60.7m
A biotechnology company, develops treatments for various medical conditions in the United States.
UNCY
US$0.58
7D
7.7%
1Y
-59.1%
Aroa Biosurgery
Market Cap: AU$172.5m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.50
7D
2.0%
1Y
-3.8%
Beit Jala Pharmaceutical
Market Cap: د.أ19.6m
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
BJP
د.أ2.80
7D
0%
1Y
n/a
Protara Therapeutics
Market Cap: US$158.5m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$4.31
7D
14.9%
1Y
7.8%
ImmunoPrecise Antibodies
Market Cap: US$17.6m
A biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies.
IPA
US$0.38
7D
2.3%
1Y
-72.5%
High Tide
Market Cap: CA$281.5m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.48
7D
5.1%
1Y
48.7%
JSP Pharmaceutical Manufacturing (Thailand) Public
Market Cap: ฿764.1m
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
JSP
฿1.67
7D
-1.8%
1Y
-34.3%
Alliance Pharma
Market Cap: UK£347.0m
Acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.
APH
UK£0.64
7D
0.2%
1Y
76.3%
Zentalis Pharmaceuticals
Market Cap: US$126.1m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
ZNTL
US$1.77
7D
-1.1%
1Y
-87.2%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$885.2m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.62
7D
8.0%
1Y
-12.4%
NextCell Pharma
Market Cap: SEK 242.7m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 3.32
7D
-0.6%
1Y
-2.1%
Arovella Therapeutics
Market Cap: AU$106.4m
A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.
ALA
AU$0.10
7D
5.0%
1Y
-28.8%
Pyxis Oncology
Market Cap: US$66.0m
A clinical stage company, engages in the development of therapeutics to treat cancers.
PYXS
US$1.11
7D
3.7%
1Y
-77.3%
Cabaletta Bio
Market Cap: US$89.0m
A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases.
CABA
US$1.82
7D
2.8%
1Y
-89.9%
Genetic Signatures
Market Cap: AU$126.1m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.56
7D
6.7%
1Y
-16.5%
Futura Medical
Market Cap: UK£36.0m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.12
7D
-8.8%
1Y
-70.4%
Covalon Technologies
Market Cap: CA$63.9m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.33
7D
0%
1Y
73.9%
Decibel Cannabis
Market Cap: CA$40.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.07
7D
0%
1Y
-41.7%
Allogene Therapeutics
Market Cap: US$421.5m
A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
ALLO
US$1.94
7D
-5.4%
1Y
-53.8%
Protalix BioTherapeutics
Market Cap: US$164.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally.
PLX
US$2.24
7D
-3.9%
1Y
76.4%
Genelux
Market Cap: US$116.0m
A clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
GNLX
US$3.40
7D
-10.1%
1Y
-42.2%
Xenetic Biosciences
Market Cap: US$5.4m
A biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers.
XBIO
US$3.50
7D
-3.8%
1Y
-17.6%
Northeast Pharmaceutical Group
Market Cap: CN¥7.1b
Engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China.
000597
CN¥5.00
7D
1.4%
1Y
3.5%
Uni-Bio Science Group
Market Cap: HK$418.0m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.073
7D
-2.7%
1Y
-13.1%
BioAtla
Market Cap: US$19.9m
A clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
BCAB
US$0.34
7D
10.9%
1Y
-85.3%
VYNE Therapeutics
Market Cap: US$27.4m
A clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions.
VYNE
US$1.85
7D
-6.6%
1Y
-3.6%
ESSA Pharma
Market Cap: US$71.9m
A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
EPIX
US$1.62
7D
0%
1Y
-82.2%
Lexeo Therapeutics
Market Cap: US$101.5m
Operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases.
LXEO
US$3.07
7D
17.2%
1Y
-80.5%
Equillium
Market Cap: US$26.7m
A clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need.
EQ
US$0.75
7D
0.4%
1Y
-71.4%
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥11.3b
Engages in the research and development, manufacturing, and sales of medicines and general health products in China.
600572
CN¥4.47
7D
1.6%
1Y
-11.0%
Botanix Pharmaceuticals
Market Cap: AU$757.6m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.43
7D
17.8%
1Y
132.4%
CSPC Pharmaceutical Group
Market Cap: HK$55.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093
HK$4.82
7D
0.6%
1Y
-26.3%
Dermata Therapeutics
Market Cap: US$4.7m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases.
DRMA
US$1.19
7D
-5.6%
1Y
-79.0%